BenevolentAI CEO and Key Executive Team

• Olivier Brandicourt

  Non-Executive Director
• Susan Liautaud

  Non-Executive Director
• Ivan Griffin

  COO and Co-Founder
• Nigel Shadbolt

  Non-Executive Director
• Anne Phelan

  CSO
• Joanna Shields

  Chief Executive Officer, Director
• Jean Raby

  Non-Executive Director
• John Orloff

  Non-Executive Director and Workforce Non-Executive Director
• Michael Brennan

  Co-Founder, Non-Executive Director
• Mark Davies

  SVP, Informatics and Data
• Rosa Vega

  VP of Technical Programme Management
• Nick Keher

  CFO
• Marcello Damiani

  Non-Executive Director
• Catherine Tucker

  VP, Business Development
• Peter Richardson

  VP, Pharmacology
• Nikki Robas

  VP, Drug Discovery
• Daniel Neil

  CTO
• Eve Berry

  VP, Head of Finance Operations
• Constantinos Neophytou

  SVP, Engineering
• Anna Fullerton-Batten

  CPO
• Dave Michalovich

  SVP, Precision Medicine
• Ed Savory

  VP, Drug Discovery
• Peter Cox

  VP, Drug Discovery
• Tom Holgate

  SVP, Finance
• Jackie Hunter

  Non-Executive Director
• Rajin Kang

  VP, Communications
• Will Scrimshaw

  General Counsel
• François Nader

  Chair
• Bryn Williams-Jones

  Senior Vice President Drug Discovery
• Jane McGuffog

  VP of Drug Discovery, DMPK
• Adepeju Oshisanya

  VP, Clinical Programmes
• Rachel Shaw

  VP, Portfolio Management
• Sarah Grey

  VP, Product
• Atima Bhatnagar

  VP, Ops & Quality
• Nicola Richmond

  VP of AI
• Fleur Wood

  VP, Investor Relations
• Matthew Fujisawa

  SVP, Strategy and Corporate Development

Source: benevolent.ai, benevolent.com, benevolent.com, benevolent.com